Final report of University Hospital Hradec Kralove to the clinical trial protocol no. VOS-AML-301

Abstract

Realization of a part of clinical trial called Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML) (VALOR)

Keywords

• vosaroxin
• cytarabine
• Refractory Acute Myeloid Leukemia